Which recent study did Dr. Marik criticize concerning his hydrocortisone‑vitamin C‑thiamine (HAT) protocol for severe sepsis and septic shock?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Which Study Did Dr. Marik Criticize?

Based on the available evidence, Dr. Marik's hydrocortisone-vitamin C-thiamine (HAT) protocol has been challenged by multiple subsequent randomized controlled trials that failed to replicate his initial findings, though the evidence does not explicitly identify a specific study he personally criticized. The most relevant context is that his 2017 retrospective before-after study showing dramatic mortality reduction has been contradicted by rigorous RCTs.

Context of Marik's Original Claims

Dr. Marik's 2017 retrospective before-after study in 94 patients with sepsis/septic shock suggested that a 4-day parenteral regimen of vitamin C (1.5 g every 6 hours), hydrocortisone, and thiamine was associated with reduced catecholamine requirements, lower SOFA scores, and decreased hospital mortality 1, 2. However, this study design was only hypothesis-generating and required confirmation by larger RCTs 2.

Subsequent Evidence Contradicting the HAT Protocol

Pediatric Guidelines Explicitly Recommend Against HAT Components

The most recent 2026 Surviving Sepsis Campaign pediatric guidelines strongly recommend against routine use of vitamin C and thiamine in septic shock 3. These guidelines cite:

  • RESPOND PICU trial (60 children): No differences in days alive and free of organ dysfunction, PICU length of stay, or shock reversal between HAT therapy and usual care 3
  • VITACiPS RCT (218 children): No differences in Sequential Organ Failure Assessment score changes, 28-day mortality, shock reversal, or adverse events 3

Adult Trial Evidence

The HYVCTTSSS trial (2020,80 patients) found no difference in 28-day mortality between HAT therapy and placebo (27.5% vs 35%, p=0.47), though it showed improvement in 72-hour SOFA score changes 4. This study was terminated after midterm analysis 4.

A comprehensive meta-analysis 5 of 9 clinical trials (1,358 participants) and 9 cohorts (339,437 participants) found:

  • No significant difference in hospital mortality (OR=0.811, p=0.304)
  • No significant difference in 28-30 day mortality (OR=1.000, p=0.998)
  • Significant improvements only in Δ-SOFA over 72 hours, vasopressor duration, and PCT clearance

Current Guideline Stance

The 2026 adult Surviving Sepsis Campaign guidelines do not include specific recommendations for or against HAT therapy, but the 2019 ESPEN guideline noted Marik's findings while emphasizing they were from a retrospective study requiring further validation 1.

Clinical Practice Implications

Do not routinely use vitamin C and thiamine (with or without hydrocortisone) for sepsis or septic shock outside of documented deficiency states 3. The evidence shows:

  • Temporal trends demonstrate IV vitamin C use peaked in early 2020 (0.6%) then declined to 0.1% by late 2021 as negative trial results emerged 6
  • Between-hospital variability remains substantial (median odds ratio 7.78), suggesting inconsistent adoption 6

Exception for Deficiency States

Consider vitamin C or thiamine supplementation only in patients with:

  • Documented malnutrition
  • Chronic illness predisposing to deficiency
  • Suspected thiamine deficiency with sustained hyperlactatemia 3

The weight of high-quality RCT evidence does not support routine HAT therapy for mortality reduction in sepsis, despite initial promising retrospective data 3, 4, 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.